Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2014-10-17 | Dr. Clemens obtained his Ph.D. in chemistry from the University College London. He has 30 years of experience in the pharmaceutical industry including roles in business and clinical operations. |
| 2015-10-16 | Dr. Clemens obtained his Ph.D. in chemistry from the University College London. He served on the board of directors of Kosan Biosciences Incorporated from 2005 to 2008. |
| 2016-10-17 | Dr. Clemens obtained his Ph.D. in Chemistry from the University College London. |
| 2017-10-16 | Dr. Clemens obtained his Ph.D. in Chemistry from the University College London. He has a long and distinguished career in the pharmaceutical industry, highlighted by 25 years at Labratorios Syntex SA and Hoffman-La Roche in a number of development, sales and marketing positions. |
| 2018-10-11 | Dr. Clemens obtained his Ph.D. in Chemistry from the University College London. |
| 2019-10-23 | Dr. Clemens obtained his Ph.D. in Chemistry from the University College London. |
| 2020-10-27 | Dr. Clemens obtained his Ph.D. in Chemistry from the University College London. |
| 2021-10-28 | Dr. Clemens obtained his Ph.D. in Chemistry from the University College London. He has held executive roles in pharmaceutical companies including Roche. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22